Efficacy of Nilotinib (AMN107) in Patients (Pts) with Newly Diagnosed, Previously Untreated Philadelphia Chromosome (Ph)-Positive Chronic Myelogenous Leukemia in Early Chronic Phase (CML-CP).
Title:
Efficacy of Nilotinib (AMN107) in Patients (Pts) with Newly Diagnosed, Previously Untreated Philadelphia Chromosome (Ph)-Positive Chronic Myelogenous Leukemia in Early Chronic Phase (CML-CP).
Author:
Cortes, Jorge O'Brien, Susan Jabbour, Elias Ferrajoli, Alexandra Borthakur, Gautam Burger, Jan Wierda, William Garcia-Manero, Guillermo Thomas, Michelle Letvak, Laurie Kantarjian, Hagop